Panacea Biotec Ltd. Financials: Quarterly Results
Revenue
169.3
Cr.
PAT
-1
Cr.
EBITDA
-2.76
Cr.
Panacea Biotec Ltd. Q4FY26 Financial Metrics
| Indicator | Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 166.75 | 165.19 | 141.13 | 166.70 | 132.53 |
| Total Income From Operations (Cr.) | 166.75 | 165.19 | 141.13 | 166.70 | 132.53 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | -2.76 | 5.57 | -19.73 | -3.90 | -26.71 |
| P/L Before Exceptional Items & Tax (Cr.) | -3.96 | 3.72 | -21.87 | -4.76 | -27.75 |
| P/L After Tax from Ordinary Activities (Cr.) | -1 | 3.89 | -14.01 | 3.96 | -1.99 |
| Net Profit/Loss For the Period (Cr.) | -1 | 3.89 | -14.01 | 3.96 | -1.99 |
| Basic EPS | -0.08 | 0.65 | -2.27 | 0.66 | -0.31 |
FAQs
Panacea Biotec Ltd. announced its quarterly results for Q4 FY2026 on June 1, 2026.
In Q4 FY2026, Panacea Biotec Ltd. are as follows:
Revenue: ₹169.3 crore
Net Profit: ₹-1 crore.
For Q4 FY2026, Panacea Biotec Ltd. posted ₹169.3 crore in revenue and ₹-1 crore in net profit.
Past quarterly results for Panacea Biotec Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.